References
- Blumberg A. L., Nelson D. F., Gramkowski M., Glover D., Glick J. M., Yuhas J. M., Kigerman M. M. Clinical trials of WR 2721 with radiation therapy. International Journal of Radiation, Oncology, Biology, Physics 1982; 8: 561–563
- Brown D. Q., Shaw L. M., Pittock J. W., Mann D. J. Modification of WR 2721 toxicity and radioprotection by an inhibitor of alkaline phosphatase. Chemical Modifiers in Cancer Treatment. 1985; 7–18, Clearwater, (1985)
- Lespinasse F., Oiry J., Fatome M., Ardouin P., Imbach J. L., Malaise E. P., Guichard M. Radioprotection of EMT6 tumor by a new class of radioprotectors based on a pseudo‐peptide cysteamine combination. International Journal of Radiation, Oncology, Biology, Physic 1985; 11: 1035–1038
- Madelmont J. C., Parry D., Moreau M. F., Godeneche D., Oiry J., Imbach J. L. Marquage par 14C due S‐acetyl‐N‐glycyl cysteamine (I 102). Journal of Labelled Compounds 1986; 23: 569–575
- Mori T., Watanabe M., Horikawa M., Nikaido P., Kimura H., Abyama T., Sugahara T. WR2721, its derivatives and their radioprotective effects on mammalian cell cultures. International Journal of Radiation, Oncology, Biology, Physics 1983; 44: 41–53
- Oiry J., Pue J. Y., Imbach J. L., Fatome M., Sentenac‐Roumanou H., Lion C. Synthesis and radioprotective activity of new cysteamine and cystamine derivations. Journal of Medicinal Chemistry 1984; 29: 2217–2225
- Phillips P. Rationale for initial clinical trials and future development of radioprotectors. Cancer Clinical Trials 1980; 3: 165–173
- Purdie J. W. A comparative study of the radioprotective effect of cysteamine, WR 2721 and WR 1067 in cultured human cells. Radiation Research 1979; 77: 303–311
- Rasey J. S., Grunbaum Z., Krohn K. A., Menard T. W., Spence A. M. Biodistribution of the radioprotective Drug 35S. Labelled 3‐Amino‐2‐hydroxypropyl phosphorothioate (WR 77913). Radiation Research 1985; 102: 130–137
- Rasey J. S., Krohn K. A., Grunbaum M. Z., Spence A. M., Menard T. W., Wade R. A. Synthesis, biodistribution and autoradiography of radio‐labeled S‐2‐(3‐Methylamino‐propylamino) ethylphosphorothioic acid (WR 3689). Radiation Research 1986; 106: 366–379
- Washburn L. C., Carlton J. E., Hayes R. L., Yuhas J. M. Distribution of WR 2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species. Radiation Research 1974; 59: 475–483
- Weisiger R. A., Jacoby W. B. S‐methylation: Thiol S‐methyl transferase. Enzymatic Basis of Detoxication, W. B. Jacoby. Academic Press, New York 1980; Vol. II: 131–140
- Yuhas J. M. Active versus passive absorption kinetics as a basis for selective protection of normal tissues by S‐2‐(3‐aminopropylamine)‐ethylphosphorothioic acid. Cancer Research 1980; 40: 1519–1524
- Yuhas J. M., Storer J. B. Differential chemoprotection of normal and malignant tissues. Journal of National Cancer Institute 1969; 42: 331–335